Problems with Combining M.E. and CFS Under One Diagnosis

Purpose

This page explains the key issues that arise when Myalgic Encephalomyelitis (M.E.) and Chronic Fatigue Syndrome (CFS) are treated as the same condition. It highlights how broad diagnostic criteria can lead to misdiagnosis, confusion in research, and inappropriate clinical care.

Key Points

1. Core Problem

• Broad fatigue-based criteria (such as Fukuda) group together different conditions
• These criteria do not require the hallmark feature of M.E.: Post-Exertional Neuroimmune Exhaustion (PENE)
• This results in mixed patient groups with different underlying illnesses

2. Impact on Research

• Heterogeneous patient groups make it difficult to:
  • Identify clear biological mechanisms
  • Find reliable biomarkers
  • Develop effective treatments
• Combining M.E. patients with broader CFS groups weakens research accuracy
• Conclusions drawn may not reflect true M.E. biology

3. Diagnostic Confusion

• M.E. and CFS are often incorrectly assumed to be identical
• Different diagnostic criteria lead to inconsistent classification
• Many individuals diagnosed with CFS do not meet stricter M.E. criteria
• This blurring of definitions distorts prevalence and understanding

4. Importance of Accurate Classification

More precise grouping of patients should include:

• Presence of PENE
• Neurological impairment
• Autonomic dysfunction
• Immune abnormalities
• Disease onset and severity

Accurate stratification improves:

• Clarity in diagnosis
• Consistency in research
• Relevance of findings

5. High Rates of Misdiagnosis

• A significant proportion of patients diagnosed with CFS may have other conditions
• Studies suggest:
  • Around 28–33% of specialist referrals receive an alternative diagnosis
  • Up to 40–50% may not have M.E./CFS
• Common misdiagnoses include:
  • Depression
  • Anxiety disorders
  • Sleep disorders
  • Other chronic illnesses

6. Causes of Misdiagnosis

• Lack of clear diagnostic tests or biomarkers
• Limited awareness among healthcare professionals
• Misapplication or inconsistent use of diagnostic criteria

At the same time:

• A large percentage of people with M.E. remain undiagnosed

7. Clinical Consequences

• Patients may receive inappropriate treatment
• Research findings may not apply to true M.E. cases
• Understanding of the disease is weakened
• Progress in developing treatments is slowed

Target Audience

This information is intended for:

• People living with M.E. or diagnosed with CFS
• Carers and family members
• Healthcare professionals
• Researchers and advocates

Overall Outcome

This page highlights that combining M.E. and CFS under a single diagnosis creates significant problems in both clinical care and research. It emphasizes the need for:

• Clear diagnostic criteria
• Accurate patient classification
• Recognition of M.E. as a distinct neuroimmune disease

Improving diagnostic precision will:

• Reduce misdiagnosis
• Strengthen research outcomes
• Support more effective and appropriate patient care

Key Summary Statement

Combining M.E. and CFS under broad criteria leads to misdiagnosis, weakens research, and obscures the distinct biological nature of M.E., making accurate classification essential for progress.